KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Assets (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Return on Assets data on record, last reported at 0.04% in Q4 2025.

  • For Q4 2025, Return on Assets rose 17.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, up 17.0%, while the annual FY2025 figure was 0.04%, 16.0% up from the prior year.
  • Return on Assets reached 0.04% in Q4 2025 per EBS's latest filing, down from 0.05% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.14% in Q1 2021 and bottomed at 0.24% in Q2 2023.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.04% recorded in 2025.
  • Peak YoY movement for Return on Assets: fell -27bps in 2023, then increased 17bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.08% in 2021, then crashed by -198bps to 0.07% in 2022, then plummeted by -224bps to 0.24% in 2023, then soared by 44bps to 0.13% in 2024, then soared by 128bps to 0.04% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.04% in Q4 2025, 0.05% in Q3 2025, and 0.13% in Q4 2024.